nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.06.2014 | Book Review

Paul S. Sidhu, Suzanne M. Ryan, Phillip F.C. Lung (Eds): FRCR 2B Viva: A Case-based Approach

Georg Thieme Verlag KG, Stuttgart, 2013; ISBN 978-3-13-166291-0

verfasst von: Valentina Piscopo, Luigi Mansi

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Excerpt

This is one of the Fellowship of the Royal College of Radiologists (FRCR) part 2B Viva examination books available on the market. The editors Paul S. Sidhu, Professor of Imaging Sciences, Suzanne M. Ryan, Consultant Gastrointestinal and Abdominal Radiologist, and Phillip F.C. Lung, Subspecialty Fellow in Gastrointestinal Radiology, all working at King’s College in London, obtained the contributions of specialist radiologists experienced in the topic under discussion, working in collaboration with a recently successful FRCR part 2 candidate. The foreword was written by Philip Gishen, Professor at Imperial College. …

Titel: Paul S. Sidhu, Suzanne M. Ryan, Phillip F.C. Lung (Eds): FRCR 2B Viva: A Case-based Approach
Georg Thieme Verlag KG, Stuttgart, 2013; ISBN 978-3-13-166291-0
verfasst von: Valentina Piscopo
Luigi Mansi
Publikationsdatum: 01.06.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 6/2014
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-013-2663-9

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2014

Radiolabelled GLP-1 receptor antagonist binds to GLP-1 receptor-expressing human tissues

Twins in spirit part II: DOTATATE and high-affinity DOTATATE—the clinical experience

Diagnostic accuracy of 18F-FDG PET/CT for detection of suspected recurrence in patients with oesophageal carcinoma

18F-FLT and 18F-FDOPA PET kinetics in recurrent brain tumors

PET/MR attenuation correction: where have we come from and where are we going?

FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)